We have located links that may give you full text access.
Throwing the dart blind-folded: comparison of computed tomography versus magnetic resonance imaging-guided brachytherapy for cervical cancer with regard to dose received by the 'actual' targets and organs at risk.
Journal of Contemporary Brachytherapy 2017 October
Purpose: Computed tomography (CT) is inferior to magnetic resonance imaging (MRI) in cervical tumor delineation, but similar in identification of organs at risk (OAR). The trend to over-estimate high-risk and low-risk clinical target volume (HRCTV, IRCTV) on CT can lead to under-estimation of dose received by 90% (D90 ) of the 'actual' CTV. This study aims to evaluate whether CT-guided planning delivers adequate dose to the 'actual' targets while spares the OAR similarly.
Material and methods: MRI-guided high-dose-rate image-guided brachytherapy (IGBT) was performed in 11 patients. The pre-brachytherapy CTs were retrospectively contoured to generate CT-guided plans. MRI-based contours (HRCTVmri , IRCTVmri , bladdermri , rectummri , and sigmoidmri ) were fused to CT plans for dosimetric comparison with MRI-guided plans. Paired 2-tailed t -test and Wilcoxon signed-rank test were used to analyze data.
Results: 63.6% of CT plans achieved the HRCTVmri D90 constraint (≥ 7.2 Gy in one fraction), compared with 90.9% for MRI plans. > 90% of both modalities achieved the OAR's constraints (EMBRACE). The percentage of CT and MRI plans that achieved the aims (EMBRACE II) for bladder, rectum, and sigmoid were 36.4% vs. 81.8%, 63.6% vs. 63.6%, and 72.7% vs. 72.7%, respectively. There were no statistically significant differences in HRCTVmri D90 , IRCTVmri D90 , or dose received by the most exposed 2 cm3 (D2cc ) of OARmri between the modalities. Excluding the CT plans not achieving HRCTVmri D90 constraint, there were significant increase in bladdermri D2cc , rectummri D2cc , and sigmoidmri D2cc , compared with MRI plans (0.9 Gy/Fr, 95% CI 0.2-1.5, p = 0.018; 0.9 Gy/Fr, 95% CI 0.3-1.4, p = 0.009; 0.5 Gy/Fr, 95% CI 0.2-0.9, p = 0.027, respectively).
Conclusions: MRI-based IGBT remains the gold standard. CT planning may compromise HRCTVmri D90 or increase OARmri D2cc , which could decrease local control or increase treatment toxicity.
Material and methods: MRI-guided high-dose-rate image-guided brachytherapy (IGBT) was performed in 11 patients. The pre-brachytherapy CTs were retrospectively contoured to generate CT-guided plans. MRI-based contours (HRCTVmri , IRCTVmri , bladdermri , rectummri , and sigmoidmri ) were fused to CT plans for dosimetric comparison with MRI-guided plans. Paired 2-tailed t -test and Wilcoxon signed-rank test were used to analyze data.
Results: 63.6% of CT plans achieved the HRCTVmri D90 constraint (≥ 7.2 Gy in one fraction), compared with 90.9% for MRI plans. > 90% of both modalities achieved the OAR's constraints (EMBRACE). The percentage of CT and MRI plans that achieved the aims (EMBRACE II) for bladder, rectum, and sigmoid were 36.4% vs. 81.8%, 63.6% vs. 63.6%, and 72.7% vs. 72.7%, respectively. There were no statistically significant differences in HRCTVmri D90 , IRCTVmri D90 , or dose received by the most exposed 2 cm3 (D2cc ) of OARmri between the modalities. Excluding the CT plans not achieving HRCTVmri D90 constraint, there were significant increase in bladdermri D2cc , rectummri D2cc , and sigmoidmri D2cc , compared with MRI plans (0.9 Gy/Fr, 95% CI 0.2-1.5, p = 0.018; 0.9 Gy/Fr, 95% CI 0.3-1.4, p = 0.009; 0.5 Gy/Fr, 95% CI 0.2-0.9, p = 0.027, respectively).
Conclusions: MRI-based IGBT remains the gold standard. CT planning may compromise HRCTVmri D90 or increase OARmri D2cc , which could decrease local control or increase treatment toxicity.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app